dimethyl aminomethylphosphonate hydrochloride | 50918-70-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机膦酸及其衍生物
• 英文名称: dimethyl aminomethylphosphonate hydrochloride
• 英文别名: Dimethyl (aminomethyl)phosphonate hydrochloride；dimethoxyphosphorylmethanamine;hydrochloride
• CAS: 50918-70-2
• 化学式: C₃H₁₀NO₃P*ClH
• 分子量: 175.552
• InChiKey: FNAUIPGNLGDWRB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.81
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  61.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  dimethyl aminomethylphosphonate hydrochloride 在 盐酸 作用下， 反应 8.0h， 生成 氨甲基膦酸
  参考文献：
  名称：

  Tritylamine (Triphenylmethylamine) in Organic Synthesis; I. The Synthesis ofN-(Triphenylmethyl)alkanimines, 1-(Triphenylmethylamino)alkylphosphonic Esters, and 1-Aminoalkylphosphonic Acids and Esters

  摘要：

  三甲胺（氨的合成类似物）在制备未知的N-(三苯甲基)烷基亚胺中的应用已被描述。这些亚胺是制备1-(三苯甲基氨基)烷基膦酸酯的便利合成子，后者可作为合成1-氨基烷基膦酸及其衍生物的起始材料。

  DOI：

  10.1055/s-1988-27576
• 作为产物：
  描述：

  dimethyl ((tritylamino)methyl)phosphonate 在 盐酸 作用下， 以 甲醇 为溶剂， 反应 0.25h， 生成 dimethyl aminomethylphosphonate hydrochloride
  参考文献：
  名称：

  Tritylamine (Triphenylmethylamine) in Organic Synthesis; I. The Synthesis ofN-(Triphenylmethyl)alkanimines, 1-(Triphenylmethylamino)alkylphosphonic Esters, and 1-Aminoalkylphosphonic Acids and Esters

  摘要：

  三甲胺（氨的合成类似物）在制备未知的N-(三苯甲基)烷基亚胺中的应用已被描述。这些亚胺是制备1-(三苯甲基氨基)烷基膦酸酯的便利合成子，后者可作为合成1-氨基烷基膦酸及其衍生物的起始材料。

  DOI：

  10.1055/s-1988-27576

文献信息

• Synthesis and Plant Growth Regulating Activity of New Triazolo- and Pyrazolopyrimidine Derivatives Of Aminomethyl, Aminoalkyloxymethyl Dimethylphosphine Oxides and (Aminomethane)Phosphonic Acid Esters
  作者：Elena Stanoeva、Sabi Varbanov、Vera Alexieva、Iskren Sergiev、Vesselina Vasileva、Marieta Rashkova、Angelina Georgieva

  DOI：10.1080/10426500008076331

  日期：2000.2

  Abstract New triazolo[4,5-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives of aminomethyl-and aminomethyloxymethyl dimethylphosphine oxides 8–14 as well as of esters of (aminomethane) phosphonic acid 18–20 were synthesized. The structure of the compounds prepared was confirmed by means of elemend analysis, IR, 1H- and 31P(1H)-NMR spectroscopy. Tertiary phosphine oxides 8, 9 and 12 as well as

  摘要 合成了氨甲基和氨甲氧基甲基二甲基膦氧化物 8-14 以及（氨基甲烷）膦酸酯 18-20 的新三唑并[4,5-d]嘧啶和吡唑并[3,4-d]嘧啶衍生物。制备的化合物的结构通过元素分析、IR、1H-和31P(1H)-NMR光谱证实。叔氧化膦 8、9 和 12 以及膦酸酯 20 显示出除草和植物生长调节活性。
• Cephalosporin compounds
  申请人：Merck & Co., Inc.

  公开号：US03962224A1

  公开（公告）日：1976-06-08

  Novel 7-azido-3-cephem compounds are prepared via .alpha.-amino-phosphonoacetate esters. The cephem compounds are intermediates for the preparation of novel and known useful antibiotic cephalosporins.

  通过α-氨基-磷酸酯酯制备新型7-偶氮基-3-头孢烯化合物。这些头孢烯化合物是制备新型和已知有用的抗生素头霉素的中间体。
• Acyl derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US04250085A1

  公开（公告）日：1981-02-10

  Peptide derivatives provided by the present invention are compounds of the general formula ##STR1## wherein R.sup.1 represents a hydrogen atom or the methyl or hydroxymethyl group or a mono-, di- or trihalomethyl mgroup; R.sup.2 represents the characterizing group of an .alpha.-amino acid of the type normally found in proteins or a lower alkyl or hydroxy- (lower alkyl) group other than the characterising group of an .alpha.-amino acid of the type normally found in proteins; R.sup.3 represents a lower alkyl, lower cycloalkyl, lower alkenyl, aryl or aryl-(lower alkyl) group; R.sup.4 represents a hydrogen atom or a lower alkyl group; n stands for 1,2 or 3; the configuration at the carbon atom designated as (a) is (R) when R.sup.1 represents other than a hydrogen atom and the configuration at the carbon atom designated as (b) is (L) when R.sup.2 represents other than a hydrogen atom, and pharmaceutically acceptable salts thereof. The compounds exhibit activity as antibacterial agents against a range of gram-positive and gram-negative bacteria. Also disclosed are intermediates and a process for the production of the end product.

  本发明提供的肽衍生物是具有一般式##STR1##的化合物，其中R.sup.1代表氢原子或甲基或羟甲基基团或单、二或三卤甲基基团；R.sup.2代表通常在蛋白质中发现的α-氨基酸的特征基团或低烷基或除了通常在蛋白质中发现的α-氨基酸的特征基团以外的羟基-(低烷基)基团；R.sup.3代表低烷基、低环烷基、低烯基、芳基或芳基-(低烷基)基团；R.sup.4代表氢原子或低烷基基团；n代表1、2或3；当R.sup.1代表除氢原子以外的其他基团时，指定为(a)的碳原子处的构型为(R)，当R.sup.2代表除氢原子以外的其他基团时，指定为(b)的碳原子处的构型为(L)，以及其药学上可接受的盐。这些化合物表现出抗一系列革兰氏阳性和革兰氏阴性细菌的活性。还披露了中间体和生产终产品的方法。
• Peptide derivatives of phosphonic and phosphinic acids and intermediates
  申请人：Hoffmann-La Roche Inc.

  公开号：US04016148A1

  公开（公告）日：1977-04-05

  The present disclosure relates to peptide derivatives. More particularly, the disclosure is concerned with peptide derivatives of phosphonic and phosphinic acids, a process for the manufacture thereof and pharmaceutical preparations containing same.

  本公开涉及肽衍生物。更具体地，涉及磷酸和亚磷酸的肽衍生物，其制造过程以及含有它们的制药制剂。
• Macrocyclic Inhibitors of Penicillopepsin. 1. Design, Synthesis, and Evaluation of an Inhibitor Bridged between P1 and P3
  作者：J. Hoyt Meyer、Paul A. Bartlett

  DOI：10.1021/ja973715j

  日期：1998.5.1

  The macrocyclic peptidyl phosphonate 1-L was designed on the basis of the conformation of an acyclic analogue (4) bound to the aspartic protease penicillopepsin. This material and the two acyclic comparison compounds 2-L and 3 were synthesized and evaluated as inhibitors; their binding affinity was found to be inversely related to the degree of conformational flexibility across the series: 3 (K-i = 110 mu M), 2-L (K-i = 7.6 mu M), 1-L (K-i = 0.80 mu M). NMR methods in conjunction with molecular modeling were used to assign the stereochemical configurations of the precursor 16-L and its diastereomer 16-D and to determine the solution conformations of the macrocyclic ring systems. The conformation of the peptide backbone in 1-L closely approximates that desired for a mimic of the lead inhibitor 4, and it appears that the low-energy conformation of 1-L can be accommodated in the pencillopepsin active site without significant distortion.